BIONANO GENOMICS INC (BNGO)
US09075F3055 - Common Stock
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript
BNGO earnings call for the period ending September 30, 2024.
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress...
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024...
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered...
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024
Special Meeting of Stockholders Adjourned Due to Lack of Quorum...
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended...
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript
BNGO earnings call for the period ending June 30, 2024.
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the second quarter of ...
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress...
Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and...
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief...
3 Quantum AI Stocks That Could Redefine Computing
Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants...
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants...
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia...
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
Bionano announces software marketing agreement with Revvity for newborn sequencing research workflow....
3 Sorry Healthcare Stocks to Sell in May While You Still Can
Steer clear of these three companies facing significant challenges. Discover why these are risky healthcare stocks to sell.
The 3 Best Healthcare Stocks to Buy in May 2024
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.
BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the first quarter of 2...
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
BNGO earnings call for the period ending March 31, 2024.
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1...
3 Contrarian Investments to Make Now for Massive Upside Potential
A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive.
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural...
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules...
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics
A peer-reviewed study compared optical genome mapping (OGM) to classical cytogenetic techniques used for analysis of solid tumor cancer samples. ...
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System
Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical...
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
BNGO earnings call for the period ending December 31, 2023.
BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023
BNGO stock results show that Bionano Genomics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the fourth quarter of ...
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024
Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022FY 2023 revenue was $36.1 million, which represents a 30% increase over FY...
Bionano to Present at TD Cowen’s 44th Annual Health Care Conference
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief...
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast...